REESE STANLEY ARTHUR
Known title: PresidentCIK: 0001238395
Associated companies
Transaction History
| AIFF | ▼ Sell | Other | 100,000 | $35K | 7/15/2022 | View on chart |
| AIFF | ▼ Sell | Other | 30,435 | $35K | 7/15/2022 | View on chart |
| AIFF | ▼ Sell | Other | 50,000 | $8K | 3/18/2022 | View on chart |
| AIFF | ▲ Buy | Grant | 10,000 | $20K | 8/26/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
Firefly Neuroscience Partners with Neurosigma for Pediatric ADHD Care
Firefly Neuroscience announced a partnership with Neurosigma to expand non-drug treatment options for pediatric ADHD. This move aims to broaden the company's clinical reach in the neurotechnology sector. The stock is currently trading within its 52-week range, with recent volume reflecting interest in this strategic development.
Firefly Neuroscience Partners with Neurosigma for Pediatric ADHD Care. Firefly Neuroscience announced a partnership with Neurosigma to expand non-drug treatment options for pediatric ADHD. This move aims to broaden the company's clinical reach in the neurotechnology sector. The stock is currently trading within its 52-week range, with recent volume reflecting interest in this strategic development.